FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Co-Diagnostics's Free Cash Flow for the
three
months ended in Dec. 2023 was $-5.24 Mil. Co-Diagnostics's Revenue for the
three
months ended in Dec. 2023 was $3.56 Mil. Therefore, Co-Diagnostics's FCF Margin % for the quarter that ended in Dec. 2023 was -147.51%.
As of today, Co-Diagnostics's current FCF Yield % is -64.66%.
The historical rank and industry rank for Co-Diagnostics's FCF Margin % or its related term are showing as below:
CODX'
s FCF Margin % Range Over the Past 10 Years
Min: -41750 Med: -1483.27 Max: 41.28
Current: -344.2
During the past 9 years, the highest FCF Margin % of Co-Diagnostics was 41.28%. The lowest was -41750.00%. And the median was -1483.27%.
CODX's FCF Margin % is ranked worse than 87.05% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: -7.185
vs CODX: -344.20
Co-Diagnostics FCF Margin % Historical Data
The historical data trend for Co-Diagnostics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Co-Diagnostics Annual Data
Trend
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
FCF Margin %
-2,622.33
36.74
41.28
15.02
-344.20
Co-Diagnostics Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
FCF Margin %
-307.14
-943.36
-2,875.25
-278.02
-147.51
Competitive Comparison
For the Medical Devices subindustry, Co-Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Co-Diagnostics FCF Margin % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Co-Diagnostics's FCF Margin % falls into.
Co-Diagnostics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Co-Diagnostics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Co-Diagnostics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Co-Diagnostics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Co-Diagnostics (Co-Diagnostics) Business Description
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CODX has been successfully added to your 